recombinant protein (AC Immune/Essex Bio-Technology)

N/A

Report date: 2025/03/20 09:43:57

Base Information

Drug Namerecombinant protein (AC Immune/Essex Bio-Technology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNerve Degeneration +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesEssex Bio-Technology LtdAc Immune Sa
Inactive CompaniesN/A
Active IndicationsNerve Degeneration +[2] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A